Eli Lilly's Zepbound delivers up to 21% weight loss through a groundbreaking dual-hormone mechanism that's reshaping obesity treatment. Join host Julia Cartwright as she decodes the science, clinical trial results, and real-world access barriers behind this revolutionary injection. Each episode stands alone, exploring a different facet of medicine's newest metabolic game-changer. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.